APO Research
Talk to an analyst

APO RESEARCH · REPORT

Seasonal Influenza Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Research

Seasonal Influenza Vaccines Industry Research Report 2026

19 December 2025147 pages

Choose your research edition.

Industry ResearchSeasonal Influenza Vaccines Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Seasonal Influenza Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Seasonal Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Seasonal Influenza Vaccines Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Seasonal Influenza Vaccines Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Seasonal Influenza Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Seasonal Influenza Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Seasonal Influenza Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Seasonal Influenza Vaccines include Changsheng Bio-Technology, Sanofi, Novartis International AG, Merck & Co., Inc., Pfizer Inc, GlaxoSmithKline plc, AstraZeneca, Viatris Inc. and Vaxess Technologies Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Seasonal Influenza Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Seasonal Influenza Vaccines Market by Company

Changsheng Bio-Technology

Sanofi

Novartis International AG

Merck & Co., Inc.

Pfizer Inc

GlaxoSmithKline plc

AstraZeneca

Viatris Inc.

Vaxess Technologies Inc

Sinovac Biotech Ltd

SINOVAC

OSIVAX

Jiangsu Simcere Vaxtec Bio-pharmaceutical

EMERGEX VACCINES

EMERGENT

Dalian Hissen Bio-pharm

CSL Limited

Ccbio SA

Aleph Biomedical

Abbott Laboratories

Seasonal Influenza Vaccines Segment by Type

Type B

Type A (H3N2)

Type A (H1N1)

Seasonal Influenza Vaccines Segment by Application

Adults

Pediatrics

Elderly

Adolescence

Seasonal Influenza Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Seasonal Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Seasonal Influenza Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Seasonal Influenza Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Seasonal Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Seasonal Influenza Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Seasonal Influenza Vaccines Sales (W Units) of Manufacturers (2021-2026) Table 7. Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Seasonal Influenza Vaccines Revenue of Manufacturers (2021-2026) Table 9. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Seasonal Influenza Vaccines Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Seasonal Influenza Vaccines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Seasonal Influenza Vaccines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Seasonal Influenza Vaccines, Product Type & Application Table 14. Global Seasonal Influenza Vaccines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Seasonal Influenza Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Changsheng Bio-Technology Company Information Table 19. Changsheng Bio-Technology Business Overview Table 20. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio Table 22. Changsheng Bio-Technology Recent Developments Table 23. Sanofi Company Information Table 24. Sanofi Business Overview Table 25. Sanofi Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Sanofi Seasonal Influenza Vaccines Product Portfolio Table 27. Sanofi Recent Developments Table 28. Novartis International AG Company Information Table 29. Novartis International AG Business Overview Table 30. Novartis International AG Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Novartis International AG Seasonal Influenza Vaccines Product Portfolio Table 32. Novartis International AG Recent Developments Table 33. Merck & Co., Inc. Company Information Table 34. Merck & Co., Inc. Business Overview Table 35. Merck & Co., Inc. Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio Table 37. Merck & Co., Inc. Recent Developments Table 38. Pfizer Inc Company Information Table 39. Pfizer Inc Business Overview Table 40. Pfizer Inc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Pfizer Inc Seasonal Influenza Vaccines Product Portfolio Table 42. Pfizer Inc Recent Developments Table 43. GlaxoSmithKline plc Company Information Table 44. GlaxoSmithKline plc Business Overview Table 45. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio Table 47. GlaxoSmithKline plc Recent Developments Table 48. AstraZeneca Company Information Table 49. AstraZeneca Business Overview Table 50. AstraZeneca Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. AstraZeneca Seasonal Influenza Vaccines Product Portfolio Table 52. AstraZeneca Recent Developments Table 53. Viatris Inc. Company Information Table 54. Viatris Inc. Business Overview Table 55. Viatris Inc. Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Viatris Inc. Seasonal Influenza Vaccines Product Portfolio Table 57. Viatris Inc. Recent Developments Table 58. Vaxess Technologies Inc Company Information Table 59. Vaxess Technologies Inc Business Overview Table 60. Vaxess Technologies Inc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio Table 62. Vaxess Technologies Inc Recent Developments Table 63. Sinovac Biotech Ltd Company Information Table 64. Sinovac Biotech Ltd Business Overview Table 65. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio Table 67. Sinovac Biotech Ltd Recent Developments Table 68. SINOVAC Company Information Table 69. SINOVAC Business Overview Table 70. SINOVAC Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. SINOVAC Seasonal Influenza Vaccines Product Portfolio Table 72. SINOVAC Recent Developments Table 73. OSIVAX Company Information Table 74. OSIVAX Business Overview Table 75. OSIVAX Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. OSIVAX Seasonal Influenza Vaccines Product Portfolio Table 77. OSIVAX Recent Developments Table 78. Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information Table 79. Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview Table 80. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio Table 82. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments Table 83. EMERGEX VACCINES Company Information Table 84. EMERGEX VACCINES Business Overview Table 85. EMERGEX VACCINES Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio Table 87. EMERGEX VACCINES Recent Developments Table 88. EMERGENT Company Information Table 89. EMERGENT Business Overview Table 90. EMERGENT Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. EMERGENT Seasonal Influenza Vaccines Product Portfolio Table 92. EMERGENT Recent Developments Table 93. Dalian Hissen Bio-pharm Company Information Table 94. Dalian Hissen Bio-pharm Business Overview Table 95. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio Table 97. Dalian Hissen Bio-pharm Recent Developments Table 98. CSL Limited Company Information Table 99. CSL Limited Business Overview Table 100. CSL Limited Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. CSL Limited Seasonal Influenza Vaccines Product Portfolio Table 102. CSL Limited Recent Developments Table 103. Ccbio SA Company Information Table 104. Ccbio SA Business Overview Table 105. Ccbio SA Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Ccbio SA Seasonal Influenza Vaccines Product Portfolio Table 107. Ccbio SA Recent Developments Table 108. Aleph Biomedical Company Information Table 109. Aleph Biomedical Business Overview Table 110. Aleph Biomedical Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio Table 112. Aleph Biomedical Recent Developments Table 113. Abbott Laboratories Company Information Table 114. Abbott Laboratories Business Overview Table 115. Abbott Laboratories Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio Table 117. Abbott Laboratories Recent Developments Table 118. Global Seasonal Influenza Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Seasonal Influenza Vaccines Sales by Region (2021-2026) & (W Units) Table 120. Global Seasonal Influenza Vaccines Sales Market Share by Region (2021-2026) Table 121. Global Seasonal Influenza Vaccines Sales by Region (2027-2032) & (W Units) Table 122. Global Seasonal Influenza Vaccines Sales Market Share by Region (2027-2032) Table 123. Global Seasonal Influenza Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2021-2026) Table 125. Global Seasonal Influenza Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2027-2032) Table 127. North America Seasonal Influenza Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 129. North America Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units) Table 130. North America Seasonal Influenza Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Seasonal Influenza Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Seasonal Influenza Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 134. Europe Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units) Table 135. Europe Seasonal Influenza Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Seasonal Influenza Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Seasonal Influenza Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 139. Asia Pacific Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units) Table 140. Asia Pacific Seasonal Influenza Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Seasonal Influenza Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Seasonal Influenza Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 144. South America Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units) Table 145. South America Seasonal Influenza Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Seasonal Influenza Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units) Table 149. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units) Table 150. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units) Table 153. Global Seasonal Influenza Vaccines Sales by Type (2027-2032) & (W Units) Table 154. Global Seasonal Influenza Vaccines Sales Market Share by Type (2021-2026) Table 155. Global Seasonal Influenza Vaccines Sales Market Share by Type (2027-2032) Table 156. Global Seasonal Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Seasonal Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2021-2026) Table 159. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2027-2032) Table 160. Global Seasonal Influenza Vaccines Price by Type (2021-2026) & (US$/Unit) Table 161. Global Seasonal Influenza Vaccines Price by Type (2027-2032) & (US$/Unit) Table 162. Global Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units) Table 163. Global Seasonal Influenza Vaccines Sales by Application (2027-2032) & (W Units) Table 164. Global Seasonal Influenza Vaccines Sales Market Share by Application (2021-2026) Table 165. Global Seasonal Influenza Vaccines Sales Market Share by Application (2027-2032) Table 166. Global Seasonal Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Seasonal Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2021-2026) Table 169. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2027-2032) Table 170. Global Seasonal Influenza Vaccines Price by Application (2021-2026) & (US$/Unit) Table 171. Global Seasonal Influenza Vaccines Price by Application (2027-2032) & (US$/Unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Seasonal Influenza Vaccines Distributors List Table 175. Seasonal Influenza Vaccines Customers List Table 176. Seasonal Influenza Vaccines Industry Trends Table 177. Seasonal Influenza Vaccines Industry Drivers Table 178. Seasonal Influenza Vaccines Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Seasonal Influenza Vaccines Product Image Figure 5. Global Seasonal Influenza Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Seasonal Influenza Vaccines Market Size (2021-2032) & (US$ Million) Figure 7. Global Seasonal Influenza Vaccines Sales (2021-2032) & (W Units) Figure 8. Global Seasonal Influenza Vaccines Average Price (US$/Unit) & (2021-2032) Figure 9. Type B Product Image Figure 10. Type A (H3N2) Product Image Figure 11. Type A (H1N1) Product Image Figure 12. Adults Product Image Figure 13. Pediatrics Product Image Figure 14. Elderly Product Image Figure 15. Adolescence Product Image Figure 16. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Seasonal Influenza Vaccines, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Seasonal Influenza Vaccines Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Seasonal Influenza Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Seasonal Influenza Vaccines Sales by Region in 2025 Figure 22. Global Seasonal Influenza Vaccines Revenue by Region in 2025 Figure 23. North America Seasonal Influenza Vaccines Market Size by Country in 2025 Figure 24. North America Seasonal Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 25. North America Seasonal Influenza Vaccines Revenue Market Share by Country (2021-2032) Figure 26. United States Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Seasonal Influenza Vaccines Market Size by Country in 2025 Figure 29. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 30. Europe Seasonal Influenza Vaccines Revenue Market Share by Country (2021-2032) Figure 31. Germany Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Nordic Countries Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific Seasonal Influenza Vaccines Market Size by Country in 2025 Figure 38. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific Seasonal Influenza Vaccines Revenue Market Share by Country (2021-2032) Figure 40. China Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America Seasonal Influenza Vaccines Market Size by Country in 2025 Figure 49. South America Seasonal Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 50. South America Seasonal Influenza Vaccines Revenue Market Share by Country (2021-2032) Figure 51. Mexico Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa Seasonal Influenza Vaccines Market Size by Country in 2025 Figure 55. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa Seasonal Influenza Vaccines Revenue Market Share by Country (2021-2032) Figure 57. Turkey Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE Seasonal Influenza Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global Seasonal Influenza Vaccines Sales Market Share by Type (2021-2032) Figure 61. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2021-2032) Figure 62. Global Seasonal Influenza Vaccines Price (US$/Unit) by Type (2021-2032) Figure 63. Global Seasonal Influenza Vaccines Sales Market Share by Application (2021-2032) Figure 64. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2021-2032) Figure 65. Global Seasonal Influenza Vaccines Price (US$/Unit) by Application (2021-2032) Figure 66. Seasonal Influenza Vaccines Value Chain Figure 67. Seasonal Influenza Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Seasonal Influenza Vaccines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Type B
  • Type A (H3N2)
  • Type A (H1N1)
Applications
  • Adults
  • Pediatrics
  • Elderly
  • Adolescence
Companies covered
  • Changsheng Bio-Technology
  • Sanofi
  • Novartis International AG
  • Merck & Co., Inc.
  • Pfizer Inc
  • GlaxoSmithKline plc
  • AstraZeneca
  • Viatris Inc.
  • Vaxess Technologies Inc
  • Sinovac Biotech Ltd
  • SINOVAC
  • OSIVAX
  • Jiangsu Simcere Vaxtec Bio-pharmaceutical
  • EMERGEX VACCINES
  • EMERGENT
  • Dalian Hissen Bio-pharm
  • CSL Limited
  • Ccbio SA
  • Aleph Biomedical
  • Abbott Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Seasonal Influenza Vaccines Market Size (2021-2032)
  4. 2.2.2 Global Seasonal Influenza Vaccines Sales (2021-2032)
  5. 2.2.3 Global Seasonal Influenza Vaccines Market Average Price (2021-2032)
  6. 2.3 Seasonal Influenza Vaccines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Type B
  9. 2.3.3 Type A (H3N2)
  10. 2.3.4 Type A (H1N1)
  11. 2.4 Seasonal Influenza Vaccines by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Adults
  14. 2.4.3 Pediatrics
  15. 2.4.4 Elderly
  16. 2.4.5 Adolescence
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Seasonal Influenza Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Seasonal Influenza Vaccines Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global Seasonal Influenza Vaccines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Seasonal Influenza Vaccines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Seasonal Influenza Vaccines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Seasonal Influenza Vaccines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Seasonal Influenza Vaccines, Product Type & Application
  8. 3.8 Global Manufacturers of Seasonal Influenza Vaccines, Established Date
  9. 3.9 Global Seasonal Influenza Vaccines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Changsheng Bio-Technology
  2. 4.1.1 Changsheng Bio-Technology Company Information
  3. 4.1.2 Changsheng Bio-Technology Business Overview
  4. 4.1.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
  6. 4.1.5 Changsheng Bio-Technology Recent Developments
  7. 4.2 Sanofi
  8. 4.2.1 Sanofi Company Information
  9. 4.2.2 Sanofi Business Overview
  10. 4.2.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sanofi Seasonal Influenza Vaccines Product Portfolio
  12. 4.2.5 Sanofi Recent Developments
  13. 4.3 Novartis International AG
  14. 4.3.1 Novartis International AG Company Information
  15. 4.3.2 Novartis International AG Business Overview
  16. 4.3.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Novartis International AG Seasonal Influenza Vaccines Product Portfolio
  18. 4.3.5 Novartis International AG Recent Developments
  19. 4.4 Merck & Co., Inc.
  20. 4.4.1 Merck & Co., Inc. Company Information
  21. 4.4.2 Merck & Co., Inc. Business Overview
  22. 4.4.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
  24. 4.4.5 Merck & Co., Inc. Recent Developments
  25. 4.5 Pfizer Inc
  26. 4.5.1 Pfizer Inc Company Information
  27. 4.5.2 Pfizer Inc Business Overview
  28. 4.5.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
  30. 4.5.5 Pfizer Inc Recent Developments
  31. 4.6 GlaxoSmithKline plc
  32. 4.6.1 GlaxoSmithKline plc Company Information
  33. 4.6.2 GlaxoSmithKline plc Business Overview
  34. 4.6.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
  36. 4.6.5 GlaxoSmithKline plc Recent Developments
  37. 4.7 AstraZeneca
  38. 4.7.1 AstraZeneca Company Information
  39. 4.7.2 AstraZeneca Business Overview
  40. 4.7.3 AstraZeneca Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 AstraZeneca Seasonal Influenza Vaccines Product Portfolio
  42. 4.7.5 AstraZeneca Recent Developments
  43. 4.8 Viatris Inc.
  44. 4.8.1 Viatris Inc. Company Information
  45. 4.8.2 Viatris Inc. Business Overview
  46. 4.8.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
  48. 4.8.5 Viatris Inc. Recent Developments
  49. 4.9 Vaxess Technologies Inc
  50. 4.9.1 Vaxess Technologies Inc Company Information
  51. 4.9.2 Vaxess Technologies Inc Business Overview
  52. 4.9.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
  54. 4.9.5 Vaxess Technologies Inc Recent Developments
  55. 4.10 Sinovac Biotech Ltd
  56. 4.10.1 Sinovac Biotech Ltd Company Information
  57. 4.10.2 Sinovac Biotech Ltd Business Overview
  58. 4.10.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
  60. 4.10.5 Sinovac Biotech Ltd Recent Developments
  61. 4.11 SINOVAC
  62. 4.11.1 SINOVAC Company Information
  63. 4.11.2 SINOVAC Business Overview
  64. 4.11.3 SINOVAC Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 SINOVAC Seasonal Influenza Vaccines Product Portfolio
  66. 4.11.5 SINOVAC Recent Developments
  67. 4.12 OSIVAX
  68. 4.12.1 OSIVAX Company Information
  69. 4.12.2 OSIVAX Business Overview
  70. 4.12.3 OSIVAX Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 OSIVAX Seasonal Influenza Vaccines Product Portfolio
  72. 4.12.5 OSIVAX Recent Developments
  73. 4.13 Jiangsu Simcere Vaxtec Bio-pharmaceutical
  74. 4.13.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
  75. 4.13.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview
  76. 4.13.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
  78. 4.13.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
  79. 4.14 EMERGEX VACCINES
  80. 4.14.1 EMERGEX VACCINES Company Information
  81. 4.14.2 EMERGEX VACCINES Business Overview
  82. 4.14.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
  84. 4.14.5 EMERGEX VACCINES Recent Developments
  85. 4.15 EMERGENT
  86. 4.15.1 EMERGENT Company Information
  87. 4.15.2 EMERGENT Business Overview
  88. 4.15.3 EMERGENT Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 EMERGENT Seasonal Influenza Vaccines Product Portfolio
  90. 4.15.5 EMERGENT Recent Developments
  91. 4.16 Dalian Hissen Bio-pharm
  92. 4.16.1 Dalian Hissen Bio-pharm Company Information
  93. 4.16.2 Dalian Hissen Bio-pharm Business Overview
  94. 4.16.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
  96. 4.16.5 Dalian Hissen Bio-pharm Recent Developments
  97. 4.17 CSL Limited
  98. 4.17.1 CSL Limited Company Information
  99. 4.17.2 CSL Limited Business Overview
  100. 4.17.3 CSL Limited Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 CSL Limited Seasonal Influenza Vaccines Product Portfolio
  102. 4.17.5 CSL Limited Recent Developments
  103. 4.18 Ccbio SA
  104. 4.18.1 Ccbio SA Company Information
  105. 4.18.2 Ccbio SA Business Overview
  106. 4.18.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Ccbio SA Seasonal Influenza Vaccines Product Portfolio
  108. 4.18.5 Ccbio SA Recent Developments
  109. 4.19 Aleph Biomedical
  110. 4.19.1 Aleph Biomedical Company Information
  111. 4.19.2 Aleph Biomedical Business Overview
  112. 4.19.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
  114. 4.19.5 Aleph Biomedical Recent Developments
  115. 4.20 Abbott Laboratories
  116. 4.20.1 Abbott Laboratories Company Information
  117. 4.20.2 Abbott Laboratories Business Overview
  118. 4.20.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
  120. 4.20.5 Abbott Laboratories Recent Developments
5 Global Seasonal Influenza Vaccines Market Scenario by Region
  1. 5.1 Global Seasonal Influenza Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Seasonal Influenza Vaccines Sales by Region: 2021-2032
  3. 5.2.1 Global Seasonal Influenza Vaccines Sales by Region: 2021-2026
  4. 5.2.2 Global Seasonal Influenza Vaccines Sales by Region: 2027-2032
  5. 5.3 Global Seasonal Influenza Vaccines Revenue by Region: 2021-2032
  6. 5.3.1 Global Seasonal Influenza Vaccines Revenue by Region: 2021-2026
  7. 5.3.2 Global Seasonal Influenza Vaccines Revenue by Region: 2027-2032
  8. 5.4 North America Seasonal Influenza Vaccines Market Facts & Figures by Country
  9. 5.4.1 North America Seasonal Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Seasonal Influenza Vaccines Sales by Country (2021-2032)
  11. 5.4.3 North America Seasonal Influenza Vaccines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Seasonal Influenza Vaccines Market Facts & Figures by Country
  15. 5.5.1 Europe Seasonal Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Seasonal Influenza Vaccines Sales by Country (2021-2032)
  17. 5.5.3 Europe Seasonal Influenza Vaccines Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Seasonal Influenza Vaccines Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Seasonal Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Seasonal Influenza Vaccines Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Seasonal Influenza Vaccines Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Seasonal Influenza Vaccines Market Facts & Figures by Country
  36. 5.7.1 South America Seasonal Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Seasonal Influenza Vaccines Sales by Country (2021-2032)
  38. 5.7.3 South America Seasonal Influenza Vaccines Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Seasonal Influenza Vaccines Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Seasonal Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Seasonal Influenza Vaccines Sales by Type (2021-2032)
  2. 6.1.1 Global Seasonal Influenza Vaccines Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Seasonal Influenza Vaccines Revenue by Type (2021-2032)
  5. 6.2.1 Global Seasonal Influenza Vaccines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Seasonal Influenza Vaccines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Seasonal Influenza Vaccines Sales by Application (2021-2032)
  2. 7.1.1 Global Seasonal Influenza Vaccines Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Seasonal Influenza Vaccines Revenue by Application (2021-2032)
  5. 7.2.1 Global Seasonal Influenza Vaccines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Seasonal Influenza Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Seasonal Influenza Vaccines Value Chain Analysis
  2. 8.1.1 Seasonal Influenza Vaccines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Seasonal Influenza Vaccines Production Mode & Process
  5. 8.2 Seasonal Influenza Vaccines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Seasonal Influenza Vaccines Distributors
  8. 8.2.3 Seasonal Influenza Vaccines Customers
9 Global Seasonal Influenza Vaccines Analyzing Market Dynamics
  1. 9.1 Seasonal Influenza Vaccines Industry Trends
  2. 9.2 Seasonal Influenza Vaccines Industry Drivers
  3. 9.3 Seasonal Influenza Vaccines Industry Opportunities and Challenges
  4. 9.4 Seasonal Influenza Vaccines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst